Herein, we employed a global, inducible CNP null mutant mouse to study the role of CNP in the development of steatohepatitis, hepatic fibrosis, and portal hypertension using well-established CDAA and CCl4 experimental models. This evidence concerns the gene CNP and Hepatic fibrosis.